Literature DB >> 11468738

Coupled particle light scattering: a new technique for serodiagnosis of Epstein-Barr virus infection.

D G Baetens1, L M Van Renterghem.   

Abstract

The Coupled Particle Light Scattering technique was evaluated for serological diagnosis of Epstein-Barr Virus (EBV) infection. Two hundred ninety-six patient sera selected from several clinical categories (acute infection, non-primary infection, interfering non-EBV infection, non-infected) were tested for IgM and IgG antibodies (anti-VCA, anti-EBNA and anti-EA). Determination of EBV IgG with Copalis multiplex was accurate when compared with Enzygnost Anti-EBV/IgG ELISA. Although the sensitivity of Copalis IgM for acute infections was 100% a positive IgM result did not always indicate an acute infection. Strong reactivity to IgG EA (ratio 3, 1) and IgG VCA (ratio 13, 3) correlated with persistent infection or reactivation. The CopalisI has many advantages over the existing methods, such as the possibility to measure three semi-quantitative IgG responses to three different EBV antigens simultaneously. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468738     DOI: 10.1002/jmv.1080

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.

Authors:  J S Klutts; R S Liao; W M Dunne; A M Gronowski
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

2.  Evidence-based approach for interpretation of Epstein-Barr virus serological patterns.

Authors:  J S Klutts; B A Ford; N R Perez; A M Gronowski
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

3.  Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.

Authors:  M J Binnicker; D J Jespersen; J A Harring; L O Rollins; E M Beito
Journal:  Clin Vaccine Immunol       Date:  2008-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.